Min vej til at stoppe med tobak
Sammenligning af tre multikomponent-interventioner til at hjælpe voksne med at stoppe med at ryge
The overarching goal of this program of research is to reduce smoking-related health disparities by increasing smoking cessation among Black adults. The goal of this research proposal is to determine whether more intensive, culturally specific, evidence-based interventions are more effective at promoting long-term cessation and other key patient-centered outcomes compared to the usual evidence-based standard of care: services provided by a state-run quitline. This study compares the relative effectiveness of three different treatments (Standard, Intensive, and Intensive Incentivized) on long-term smoking cessation (biochemically confirmed abstinence from combusted tobacco at 26-weeks post-target quit day) among Black adults who smoke and want to quit.
Studieoversigt
Status
Status
Betingelser
Betingelser
Intervention / Behandling
Intervention / Behandling
Detaljeret beskrivelse
Primary Objective: Identify the most effective treatment for increasing long-term smoking abstinence among Black adults who smoke.
Secondary Objectives:
- Compare the 3 interventions on key patient-relevant outcomes (e.g., treatment satisfaction, smoke fewer cigarettes per day, quality of life) using validated measures collected at 8 and 26 weeks post-target quit day (TQD)
- Identify subgroups for whom these treatments are especially effective or ineffective with respect to the primary and secondary outcomes.
- Compare indices of treatment engagement (e.g., percentage of counseling sessions attended, percentage of days used nicotine patch) among Black people who smoke and are randomly assigned to the 3 different treatment conditions.
Undersøgelsestype
Undersøgelsestype
Tilmelding (Anslået)
Tilmelding
Fase
Fase
- Fase 4
Kontakter og lokationer
Studiekontakt
Studiekontakt
- Navn: Megan Piper, PhD
- Telefonnummer: 608-265-5472
- E-mail: mep@ctri.wisc.edu
Studiesteder
-
-
Arizona
-
Phoenix, Arizona, Forenede Stater, 85004
- Ikke rekrutterer endnu
- Arizona State University
-
-
Indiana
-
Indianapolis, Indiana, Forenede Stater, 46202
- Ikke rekrutterer endnu
- Indiana University
-
-
Kansas
-
Kansas City, Kansas, Forenede Stater, 66160
- Ikke rekrutterer endnu
- University of Kansas Medical Center Research Institute, Inc
-
-
Virginia
-
Richmond, Virginia, Forenede Stater, 23298
- Ikke rekrutterer endnu
- Virginia Commonwealth University
-
-
Wisconsin
-
Milwaukee, Wisconsin, Forenede Stater, 53233
- Rekruttering
- UW School of Medicine and Public Health
-
-
Deltagelseskriterier
Berettigelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- self-identify as Black
- smoke cigarettes (greater than or equal to 1 cigarette on greater than or equal to 4 days/week)
- motivated to quit smoking
- willing to discontinue any non-study smoking cessation pharmacotherapy use during study treatment.
Exclusion Criteria:
- currently taking bupropion for non-smoking cessation reasons
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Enkelt
Antal våben
Våben og indgreb
Deltagergruppe / ArmDeltagergruppe / Arm |
Intervention / BehandlingIntervention / Behandling |
|---|---|
|
Aktiv komparator: Standard Intervention
The Standard Intervention will include 2 weeks of nicotine patches + 4 quitline-style counseling phone calls. |
Patch dosing will be consistent with the package insert
Andre navne:
4, 10 to 15-minute counseling sessions (the duration of a typical quitline call) will occur via phone one week prior to the TQD, 1 day after the TQD, and 1 and 2 weeks after the TQD. |
|
Eksperimentel: Intensive Intervention
The Intensive Intervention will include 8 weeks of nicotine patches (if eligible) + 8 counseling sessions (choice of individual phone or virtual group) + the Pathways to Freedom video content on the study website with additional smoking cessation content. |
Patch dosing will be consistent with the package insert
Andre navne:
Participants will have the option of choosing 8, 30-minute counseling phone calls or 8, 60-minute video group counseling sessions Pathways to Freedom video content, a 60-minute video that addresses key issues such as emotional dependence, nicotine replacement, identifying smoking triggers, developing coping skills, and other behavioral strategies people can use to support a quit attempt. |
|
Eksperimentel: Intensive Incentivized Intervention
The Intensive Incentivized Intervention will include all components provided in the Intensive intervention (8 weeks of nicotine patches (if eligible) + 8 counseling sessions (choice of individual phone or virtual group) + the Pathways to Freedom video content on the study website with additional smoking cessation content) and up to $50 for completing counseling sessions ($5 for completing sessions 1-6 and $10 for completing sessions 7 and 8) |
Patch dosing will be consistent with the package insert
Andre navne:
Participants will have the option of choosing 8, 30-minute counseling phone calls or 8, 60-minute video group counseling sessions Pathways to Freedom video content, a 60-minute video that addresses key issues such as emotional dependence, nicotine replacement, identifying smoking triggers, developing coping skills, and other behavioral strategies people can use to support a quit attempt. up to $50 for completing counseling sessions ($5 for completing sessions 1-6 and $10 for completing sessions 7 and 8) |
Hvad måler undersøgelsen?
Primære resultatmål
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Biochemically confirmed abstinence from combusted tobacco at 26-weeks post-target quit day
Tidsramme: 26 weeks post-TQD
|
The primary outcome for this study will be biochemically confirmed (anabasine less than 2 ng/ml) 7-day point-prevalence smoking abstinence at 26- weeks post-TQD |
26 weeks post-TQD
|
Sekundære resultatmål
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Penge brugt på cigaretter pr. uge
Tidsramme: baseline, 8 og 26 uger efter TQD
|
baseline, 8 og 26 uger efter TQD
|
|
|
Biochemically confirmed abstinence from any nicotine product at 26-weeks post-target quit day
Tidsramme: 26 weeks post-TQD
|
salivary cotinine using a cut-off of less than 10 ng/ml to indicate abstinence from any nicotine product (combusted cigarettes, e-cigarettes, nicotine replacement therapy [NRT]) |
26 weeks post-TQD
|
|
Treatment Satisfaction
Tidsramme: 8 weeks post-TQD
|
Scored from 1 to 7 where higher scores indicate increased satisfaction with treatment. |
8 weeks post-TQD
|
|
Cigarettes per day
Tidsramme: baseline, 8 and 26 weeks post-TQD
|
Cigarettes per day based on the past 7 days. |
baseline, 8 and 26 weeks post-TQD
|
|
Quality of Life measured by the Medical Outcomes Study's 12-item Short Form Survey Instrument (SF-12)
Tidsramme: baseline, 8 and 26 weeks post-TQD
|
Scores range from 0 to 100 where higher scores indicate better quality of life. |
baseline, 8 and 26 weeks post-TQD
|
|
Smoking Cessation Self-efficacy using a single 10-point Likert scale
Tidsramme: baseline, 8 and 26 weeks post-TQD
|
Scores range from 1 to 10 where higher scores mean higher cessation self-efficacy. |
baseline, 8 and 26 weeks post-TQD
|
|
Psychological Distress measured by the 6-item Kessler screener (K6)
Tidsramme: baseline, 8 and 26 weeks post-TQD
|
Total range of scores is from 0-24 where higher scores mean decreased psychological distress. |
baseline, 8 and 26 weeks post-TQD
|
Samarbejdspartnere og efterforskere
Sponsor
Sponsor
Samarbejdspartnere
Samarbejdspartnere
Efterforskere
Efterforskere
- Ledende efterforsker: Megan Piper, PhD, UW School of Medicine and Public Health
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Studiestart
Primær færdiggørelse (Anslået)
Primær færdiggørelse
Studieafslutning (Anslået)
Studieafslutning
Datoer for studieregistrering
Først indsendt
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Først opslået
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering sendt
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
Andre undersøgelses-id-numre
- 2025-1697
- SMPH / CTRI (Anden identifikator: UW Madison)
- BPS-2024C1-36762 (Andet bevillings-/finansieringsnummer: PCORI)
- Protocol Version 4/6/26 (Anden identifikator: UW Madison)
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
IPD-deling Understøttende informationstype
- STUDY_PROTOCOL
- SAP
- ICF
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
produkt fremstillet i og eksporteret fra U.S.A.
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .